Kao to join Unilever and Geno’s venture to scale palm alternatives

By Julia Wray 29-Sep-2022

Geno’s technology also offers alternatives to fossil fuel-based ingredient sources

Kao to join Unilever and Geno’s venture to scale palm alternatives
Kao Corporation is joining Unilever and biotech firm Genomatica, now known as Geno, in a US$120m venture to scale alternatives to palm oil and fossil fuel-based ingredients.

The collaboration was first announced as a joint venture between Unilever and Geno in June this year.

Kao’s 130-plus years of expertise in the consumer products and chemical industries is anticipated to deepen the venture’s global reach and impact.

The Japan-based consumer goods and chemicals company said joining the venture will help it hit its climate goals, which include reducing carbon dioxide missions to zero by 2040 and becoming carbon-negative by 2050.

According to Geno, companies can reduce the carbon footprint of palm-derived ingredients by up to 50% with its plant-based alternative.

"I am delighted that Kao has had the opportunity to invest in a venture with such outstanding, cutting-edge biotechnology capabilities,” said Masahiro Katayose, Kao’s Senior Executive Officer in charge of its Chemical Business.

“Kao’s investment in this venture will make possible the provision of new eco-chemical solutions and represents an opportunity for Kao to play an even bigger role in helping consumers, customers, industry and society to realise decarbonisation and make the shift to a resource-circulating economy.”

Christophe Schilling, Geno’s CEO, added: “We’re excited to welcome Kao as a founding member to our palm kernel oil alternative venture along with Unilever.

Sign up for your free email newsletter

“Kao joining this venture is another example of Geno collaborating with world-leading brands and value-chain partners to commercialise sustainable solutions at scale that support traceable and responsible sourcing.”